- « Previous
- Clinical Pharmacology
- Next »
Pepcid
Clinical Pharmacology
Pepcid
Five published studies (Table 8) examined the effect of famotidine on gastric pH and duration of acid suppression in pediatric patients. While each study had a different design, acid suppression data over time are summarized as follows:
Table 8
| Dosage | Route | Effecta | Number of Patients (age range) |
| 0.5 mg/kg, single dose | I.V. | gastric pH > 4 for 19.5 hours (17.3, 21.8c) | 11 (5-19 days) |
| 0.3 mg/kg, single dose | I.V. | gastric pH > 3.5 for 8.7 &plsumn; 4.7b hours | 6 (2-7 years) |
| 0.4-0.8 mg/kg | I.V. | gastric pH > 4 for 6-9 hours | 18 (2-69 months) |
| 0.5 mg/kg, single dose | I.V. | a > 2 pH unit increase above baseline in gastric pH for > 8 hours | 9 (2-13 years) |
| 0.5 mg/kg b.i.d. | I.V. | gastric pH > 5 for 13.5 ± 1.8bhours | 4 (6-15 years) |
| 0.5 mg/kg b.i.d. | oral | gastric pH > 5 for 5.0 ± 1.1bhours | 4 (11-15 years) |
| a Values reported in published
literature. b Means ± SD. c Mean (95% confidence interval). |
|||
The duration of effect of famotidine I.V. 0.5 mg/kg on gastric pH and acid suppression was shown in one study to be longer in pediatric patients < 1 month of age than in older pediatric patients. This longer duration of gastric acid suppression is consistent with the decreased clearance in pediatric patients < 3 months of age (see Table 6).
Generic Name: Famotidine
- « Previous
- Clinical Pharmacology
- Next »
GI Disorders
Get the latest treatment options.
Eating With Heartburn/Acid Reflux
If you have chronic heartburn, you are at risk for GERD. If left untreated, GERD can put you at risk for cancer of the esophagus. See more WebMD Videos »
